Join the 27th Annual International Lung Cancer Congress® for a high-impact update on lung cancer care, featuring the latest in immunotherapy, targeted therapy and ADCs
👉 Don’t miss it—REGISTER FREE with code OncoAlert.
buff.ly/YnjTuRM
LIVE EVENT :Huntington Beach, California
📢 Join us at the 44th Annual Chemotherapy Foundation Symposium (CFS®): Innovative Cancer Therapy for Tomorrow 📅 November 11–13, 2026 (NY, NY🇺🇸 )
REGISTER 👉 tinyurl.com/47w67nce
HYBRID MEETING (Online and In Person)
🚨 FREE🆓 REGISTRATION with Code: OncoAlert
FDA approves belzutifan with pembrolizumab for adjuvant treatment of renal cell carcinoma
www.fda.gov/drugs/resour...
LITESPARK-022
ascopubs.org/doi/10.1200/...
Video
Video
Join PER on July 8, 2026 for Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera & Essential Thrombocythemia 🩸
REGISTER👉 tinyurl.com/3mxy4dyz
🚨 FDA Approves capivasertib Plus Abiraterone as First Targeted Therapy for PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer
Source AstraZeneca
www.astrazeneca.com/media-centre...
Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial
www.thelancet.com/journals/lan...
Get expert insights on new #ProstateCancer data emerging from ASCO 2026. Prof. Evan Yu joins COR2ED live in Chicago to share his views on how new trial data presented at the meeting could impact the clinical management of patients with prostate cancer.
Watch here👉 buff.ly/RtWHLjc
Presenting OncoAlert Horizons | Focus: Breast Cancer Educational Series 🚨In this session, we explore: Adjuvant Treatment Challenges in Early HR+/HER2− #BreastCancer Emerging Role of Next-Gen Oral SERDs
WATCH 👉 youtu.be/tH0XDWL1RDY
🧑⚕️Faculty
Dr. Prof. Dr. med. Sibylle Loibl🇩🇪and Dr. Rupert Bartsch🇩🇪
Get expert insights on the latest data in lung, prostate, GI, and breast cancers presented at #ASCO26 .
WATCH HERE👉 buff.ly/eQiz2b7
Renowned medical experts join @COR2EDMedEd in Chicago to share their views on data emerging from the meeting. How will new trial data impact clinical practice?
Lung cancer 🫁 update from #ASCO26
👉 buff.ly/9P3rYdv
Renowned lung cancer experts join our collaborators at COR2ED at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC)
@herbloong @ipreeshagul
Video
In this episode of the OncoAlert Horizons Series, leading breast cancer experts Dr. Sibylle Loibl and Dr. Rupert Bartsch discuss one of the most important topics in early breast cancer management…
